Prolactin-releasing peptide regulates the cardiovascular system via corticotrophin-releasing hormone

Journal of Neuroendocrinology

Volumn 21, Issue 6, 2009, Pages 586-593

  Yamada, T ^a   Mochiduki, A ^a   Sugimoto, Y ^a   Suzuki, Y ^b   Itoi, K ^c   Inoue, Kinji ^a  

^a SAITAMA UNIVERSITY   (Japan)

^b Tokyo College of Science   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Cardiovascular system; Corticotrophin releasing hormone; Noradrenaline; Prolactin releasing peptide; Stress

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; OXYTOCIN; PROLACTIN RELEASING FACTOR; PROTEIN C FOS; VASOPRESSIN; VASOPRESSIN ANTAGONIST;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BRAIN NERVE CELL; CARDIOVASCULAR EFFECT; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HEART RATE; LOCUS CERULEUS; MAGNOCELLULAR NUCLEUS; MALE; MEDULLA OBLONGATA; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; THALAMUS MIDLINE NUCLEUS;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CORTICOTROPIN-RELEASING HORMONE; HEART RATE; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; LOCUS COERULEUS; MALE; NEURAL PATHWAYS; NEURONS; NOREPINEPHRINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE; VASOPRESSINS;

EID: 65849529916     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2009.01875.x     Document Type: Article

References (37)

1. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing peptide in the brain. Nature 1998; 393: 272-276.
2. Matsumoto H, Noguchi J, Horikoshi Y, Kawamata Y, Kitada C, Hinuma S, Onda H, Nishimura O, Fujino M. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun 1999; 259: 321-324.
3. Maruyama M, Matsumoto H, Fujiwara K, Kitada C, Hinuma S, Onda H, Fujino M, Inoue K. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology 1999; 140: 2326-2333.
4. Fujii R, Fukusumi S, Hosoya M, Kawamata Y, Habata Y, Hinuma S, Sekiguchi M, Kitada C, Kurokawa T, Nishimura O, Onda H, Sumino Y, Fujino M. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul Pept 1999; 83: 1-10.
5. Morales T, Hinuma S, Sawchenko PE. Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurons. J Neuroendocrinol 2000; 12: 131-140.
6. Roland BL, Sutton SW, Wilson SJ, Luo L, Pyati J, Huvar R, Erlander MG, Lovenberg TW. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology 1999; 140: 5736-5745.
7. Chen C, Dun SL, Dun NJ, Chang JK. Prolactin-releasing peptide immunoreactivity in A1 and A2 noradrenergic neurones of the rat medulla. Brain Res 1999; 822: 276-279.
8. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Fujino M, Inoue K. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology 1999; 142: 2032-2038.
9. Maruyama M, Matsumoto H, Fujiwara K, Noguchi J, Kitada C, Hinuma S, Onda H, Nishimura O, Fujino M, Higuchi T, Inoue K. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Neurosci Lett 1999; 276: 193-196.
10. Samson WK, Resch ZT, Murphy TC. A novel action of the newly described prolactin-releasing peptides: Cardiovascular regulation. Brain Res 2000; 858: 19-25.
11. Marano G, Ramirez A, Mori I, Ferrari AU. Sympathectomy inhibits the vasoactive effects of nicotine in conscious rats. Cardiovasc Res 1999; 42: 201-205.
12. Teranishi Y, Tsuru H, Shimomura H, Amano T, Matsubayashi H. Compensatory vasoconstrictor effects of sodium pentobarbital on the hindquarters of conscious normotensive control and lumbar-sympathectomized Wistar rats. Auton Neurosci 2000; 82: 130-136.
13. Tarasova O, Figourina I, Zotov A, Borovik A, Vinogradova O. Effect of tail suspension on haemodynamics in intact and sympathectomized rats. Eur J Appl Physiol 2001; 85: 397-404.
14. Vallotton MB, Wuthrich RP, Lew PD, Capponi AM. Effects of vasopressin and its analogs on rat aortic smooth muscle and renal medullary tubular cells: Characterization of receptor subtypes. J Cardiovasc Pharmacol 1986; 7(Suppl 8): S5-S11.
15. Jochem J. Involvement of arginine vasopressin in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats. Inflamm Res 2004; 53: 269-276.
16. Ma S, Shipston MJ, Morilak D, Russell JA. Reduced hypothalamic vasopressin secretion underlies attenuated adrenocorticotropin stress responses in pregnant rats. Endocrinology 2005; 146: 1626-1637.
17. Vale W, Rivier C, Brown MR, Spiess J, Koob G, Swanson L, Bilezikjian L, Bloom F, Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 1983; 39: 245-270.
18. Dunn AJ, Berridge CW. Physiological and behavioural responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses? Brain Res Brain Res Rev 1990; 15: 71-100.
19. Asakura M, Nagashima H, Fujii S, Sasuga Y, Misonoh A, Hasegawa H, Osada K. Influences of chronic stress on central nervous systems. Nihon Shinkei Seishin Yakurigaku Zasshi 2000; 20: 97-105.
20. Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Behavioural effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology 2000; 22: 230-239.
21. de Kloet ER. Hormones, brain and stress. Endocr Regul 2003; 37: 51-68.
22. Reyes BA, Fox K, Valentino RJ, Van Bockstaele EJ. Agonist-induced internalization of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus. Eur J Neurosci 2006; 23: 2991-2998.
23. Sved AF, Cano G, Passerin AM, Rabin BS. The locus coeruleus, Barrington's nucleus, and neural circuits of stress. Physiol Behav 2002; 77: 737-742.
24. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd edn. Sydney: Academic Press, 1986.
25. Yao ST, Lawrence AJ. Purinergic modulation of cardiovascular function in the rat locus coeruleus. Br J Pharmacol 2005; 145: 342-352.
26. Nishimura O, Moriya T, Suenaga M, Tanaka Y, Itoh T, Koyama N, Fujii R, Hinuma S, Kitada C, Fujino M. Synthesis of new peptides with prolactin-releasing activity by a combination of recombinant DNA technology and a cysteine-specific cyanylation reaction. Chem Pharm Bull 1998; 46: 1490-1492.
27. Kavushansky A, Leshem M. Role of oxytocin and vasopressin in the transitions of weaning in the rat. Dev Psychobiol 2004; 45: 231-238.
28. Heinemann A, Horina G, Stauber RE, Pertl C, Holzer P, Peskar BA. Lack of effect of a selective vasopressin V1A receptor antagonist, SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed. Br J Pharmacol 1998; 125: 1120-1127.
29. Briscoe RJ, Cabrera CL, Baird TJ, Rice KC, Woods JH. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats. Brain Res 2000; 881: 204-207.
30. Dong HW, Gan Q, Knuepfer MM. Central corticotropin releasing factor (CRF) and adrenergic receptors mediate hemodynamic responses to cocaine. Brain Res 2001; 893: 1-10.
31. Matsumoto H, Maruyama M, Noguchi J, Horikoshi Y, Fujiwara K, Kitada C, Hinuma S, Onda H, Nishimura O, Inoue K, Fujino M. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett 2000; 285: 234-238.
32. Gimpl G, Fahrenholz F. The oxytocin receptor system: Structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
33. Michelini LC, Marcelo MC, Amico J, Morris M. Oxytocinergic regulation of cardiovascular function: Studies in oxytocin-deficient mice. Am J Physiol Heart Circ Physiol 2003; 284: H2269-H2276.
34. Petersson M, Uvnas-Moberg K. Effects of an acute stressor on blood pressure and heart rate in rats pretreated with intracerebroventricular oxytocin injections. Psychoneuroendocrinology 2007; 32: 959-965.
35. Butler PD, Weiss JM, Stout JC, Nemeroff CB. Corticotropin-releasing factor produces fear-enhancing and behavioural activating effects following infusion into the locus coeruleus. J Neurosci 1990; 10: 176-183.
36. Wynn PC, Hauger RL, Holmes MC, Millan MA, Catt KJ, Aguilera G. Brain and pituitary receptors for corticotropin releasing factor: Localization and differential regulation after adrenalectomy. Peptides 1984; 5: 1077-1084.
37. Lawrence CB, Liu YL, Stock MJ, Luckman SM. Anorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 2004; 286: 101-107.